TrialX
Image

Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients

Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients

Recruiting
18 years and older
All
Phase N/A

Overview

Non-commercial depersonalized multi-centered registry study on analysis of chronic non-infectious diseases dynamics after SARS-CoV-2 infection in adults.

Description

Non-commercial depersonalized multi-centered registry study on analysis of chronic non-infectious diseases dynamics after SARS-CoV-2 infection in cohort of Russian adult patients.

Retrospective analysis of medical histories and outcomes in adults with pre-existing conditions after SARS-CoV-2 infection and prospective monitoring of health status during 3, 6 and 12 months after discharge. Comorbidities worsening risk factors measuring through evaluation of range of indicators such as dynamics of diabetes, CKD, COPD, bronchial astma, incidence of hypertonic crises, vascular events and others.

Eligibility

Inclusion Criteria:

  • Suspected or confirmed COVID-19.

Exclusion Criteria:

  • Refuse to be involved in study;
  • Age under 18 years.

Study details
    Pulmonary Disease
    NIDDM
    diabetes mellitus
    type 2
    Diabetes Mellitus
    diabetes (pediatric)
    Coronary Artery Disease
    Coronary Artery Disease
    Chronic Obstructive Lung Disease
    Chronic Obstructive Lung Disease
    Coronary heart disease
    Vascular Diseases
    Vascular Diseases
    Upper respiratory infection
    Hypertension
    Pneumonia
    Pneumonia
    Cardiovascular Disease
    Ischemic Heart Disease
    Overweight and Obesity
    diabetes (pediatric)
    diabetes mellitus
    type 2
    COVID19
    CKD
    Cardiac Event
    SARS-CoV-2 Infection

NCT04492384

Eurasian Association of Therapists

5 August 2020

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.